Pain management strategies in adults with haemophilia: a retrospective study
X. Wang,M. Yang,S. Jackson
DOI: https://doi.org/10.1111/hae.12753
2015-11-01
Haemophilia
Abstract:Individuals with haemophilia experience acute and chronic pain which, on an average day, can reach an intensity of 5/10 [1]. Although options exist for managing acute and chronic pain, many patients with haemophilia do not achieve good control of pain. Several studies have looked at the impact of pain in severe haemophilia [2,3]; however, the management of pain in all severities of the haemophilia population have not been investigated thoroughly, especially in Canada where factor concentrates are widely available. The purpose of this study was to describe the past pain management techniques, hereafter called pain strategies, in a large haemophilia population. Particular areas of interest were the use of opiates, non-steroidal anti-inflammatory agents (NSAIDs; including celecoxib), and use of marijuana for pain. All males with a diagnosis of haemophilia A or B from a single Adult Haemophilia Centre who had an active record between 2004 (when the clinic moved to its current location) and May 2012 had their chart reviewed. Pain management strategies used during those years were categorized by type, dosage, frequency and targeted site(s). A total of 210 subjects were included, 75% with haemophilia A and 25% with haemophilia B. The prevalence of severe, moderate and mild haemophilia was 35% (n = 73), 23% (n = 49) and 42% (n = 88) respectively. The mean age was 41 years and the median 38 years (range = 17–76). Most subjects (60%, n = 126) had used a pain strategy, during the 8 year period, according to the written records. Of those using a pain strategy, 70 subjects (55%) had used acetaminophen and 30 subjects (24%) used acetaminophen in combination with codeine. NSAIDs were used in 69 subjects (55%), opiates in 32 subjects (25%) and 53 subjects (42%) used some other form of pain strategy. Most subjects (94/126) were using more than one form of pain strategy. Opiates were used either alone or in conjunction with other pain analgesics in only 15% (32/210) of the overall population. The most commonly used agents were morphine (41%, 13/32), hydromorphine (28%, 9/32), codeine (19%, 6/32) and oxycodone (16%, 5/32). When opiate use was evaluated by haemophilia severity, the prevalence was as follows; 22% (16/73) of severe, 14% (7/49) of moderate and 10% (9/88) of mild subjects had reported use of opiates. A similar trend by haemophilia severity was observed with the other pain strategies with a variation of 5%. This may have been influenced by a lack of older individuals in the severe haemophilia group (Fig. 1); thus opiate usage due to age-related factors (i.e. arthritis) is not accounted for; whereas in the milder subjects, a more representative population of older individuals survives (Fig. 1). Many patients may be reluctant to use opiates as analgesics for fear of drug dependency [4], which could explain why severe subjects, who have more potential reasons for severe pain, may choose not to use opiates. Controversies surrounding opiate usage make it difficult or unappealing for practitioners to prescribe; however, contrary to popular beliefs, the risk of dependence of opiate usage to treat chronic pain is low [5]. Celecoxib, a COX2 specific NSAID, was used in 14% (29/210) subjects as a pain strategy. Twenty-six percent of individuals with severe haemophilia used